What are the recommended follow-up protocols for patients with rheumatic heart disease to monitor for cardiac complications?

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP.

Posted: 17 August 2025Updated: 17 August 2025 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX

For patients with rheumatic heart disease, follow-up protocols primarily focus on monitoring for cardiac complications, often aligning with guidelines for heart valve disease and chronic heart failure.

  • Initial Specialist Referral and Assessment:
    • Adults with moderate or severe valve disease of any type, or bicuspid aortic valve disease of any severity (including mild), should be offered referral to a specialist .
    • People with heart failure due to valve disease should be referred for specialist assessment and advice regarding follow-up .
    • Pregnant women or women considering pregnancy with moderate or severe valve disease, bicuspid aortic valve disease (any severity with associated aortopathy), or a prosthetic valve should be referred to a cardiologist with expertise in pregnant women's care, regardless of symptoms . Specialist care should be shared between a cardiologist and obstetrician if pregnancy is considered or occurs ,.
  • General Follow-up and Monitoring for Heart Failure (Common Complication):
    • All people with chronic heart failure require regular follow-up and monitoring ,.
    • Heart failure care should be delivered by a dedicated multidisciplinary team, which may include a dedicated heart failure nurse and a pharmacist .
    • The frequency of follow-up needs to be individualized based on symptom severity, stability, treatment, and comorbidities .
    • The follow-up interval should be short (days to 2 weeks) if the person's clinical condition or drugs have changed .
    • For stable conditions, follow-up should occur at least every 6 months . This includes a clinical assessment, medication review, and assessment of renal function ,.
    • Clinical Assessment and Monitoring:
      • Assess functional capacity (e.g., using New York Heart Association classification), fluid status, cardiac rhythm (minimum of examining the pulse), cognitive status, and nutritional status ,.
      • Ask about palpitations, shortness of breath, presence of oedema, and syncopal/presynopal symptoms .
      • If syncope or presyncope occurs (unless clearly due to postural hypotension), refer to a cardiologist .
      • If an arrhythmia is suspected, arrange a 12-lead ECG or 24-hour ECG monitoring .
      • Assess fluid status by checking for changes in body weight, oedema (abdomen, sacrum, genitalia, ankles), raised jugular venous pressure, fine lung crepitations, hepatomegaly, and postural drop in blood pressure .
      • Monitor serum urea, electrolytes, and estimated glomerular filtration rate (eGFR) every 6 months .
      • Consider monitoring N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) levels in people less than 75 years of age to guide optimum drug treatment, especially for those with a higher baseline NT-pro-BNP level (greater than 2114 pg/mL) .
    • Medication Review:
      • Review the person's medications, including over-the-counter preparations, and ask about possible adverse effects ,.
      • For people taking amiodarone, offer liver and thyroid function tests and a review of side effects as part of their routine 6-monthly clinical review .
      • For people with heart failure and atrial fibrillation, follow the recommendations on anticoagulation in the NICE guideline on atrial fibrillation . In people with heart failure in sinus rhythm, anticoagulation should be considered for those with a history of thromboembolism, left ventricular aneurysm, or intracardiac thrombus . Be aware of the effects of impaired renal and liver function on anticoagulant therapies .
    • Preventive Measures and Holistic Care:
      • Offer an annual influenza vaccine and a once-only pneumococcal vaccination ,.
      • Screen for depression and anxiety . Reassess psychological status once the physical condition has stabilized if depression is likely to have been precipitated by heart failure symptoms .
      • If suitable, ensure the person has been offered referral to a supervised exercise-based group rehabilitation programme for people with heart failure, which should include psychological and education-based components .
      • Assess nutritional status; consider dietetic referral if BMI is under 18.5 kg/m2, or give advice on healthy weight if BMI is over 30 kg/m2 .
      • Provide general information about heart failure and its management, including self-care advice . Ensure sources of information and advice have been given to the person and their carers/family .
      • Offer a discussion about advance care planning and advance decisions, if appropriate, at an early stage of the disease .

Educational content only. Always verify information and use clinical judgement.

What are the recommended follow-up protocols for patients with rheumat